Your activity: 115 p.v.
< Back
Atypia and lobular carcinoma in situ: High-risk lesions of the breast
Breast ductal carcinoma in situ: Epidemiology, clinical manifestations, and diagnosis
Ductal carcinoma in situ: Treatment and prognosis
Microinvasive breast carcinoma
Breast biopsy
Breast imaging for cancer screening: Mammography and ultrasonography
Cancer risks and management of BRCA1/2 carriers without cancer
Clinical features, diagnosis, and staging of newly diagnosed breast cancer
Diagnostic evaluation of suspected breast cancer
Genetic testing and management of individuals at risk of hereditary breast and ovarian cancer syndromes
MRI of the breast and emerging technologies
Overview of hereditary breast and ovarian cancer syndromes associated with genes other than BRCA1/2
Screening for breast cancer: Evidence for effectiveness and harms
Screening for breast cancer: Strategies and recommendations
Tumor, node, metastasis (TNM) staging classification for breast cancer
Approach to the patient following treatment for breast cancer
Brain metastases in breast cancer
Breast development and morphology
Cardiotoxicity of radiation therapy for breast cancer and other malignancies
Cardiotoxicity of trastuzumab and other HER2-targeted agents
Factors that modify breast cancer risk in women
Gestational breast cancer: Epidemiology and diagnosis
Gestational breast cancer: Treatment
Hormone receptors in breast cancer: Clinical utility and guideline recommendations to improve test accuracy
Inflammatory breast cancer: Pathology and molecular pathogenesis
Overview of long-term complications of therapy in breast cancer survivors and patterns of relapse
Overview of the treatment of newly diagnosed, invasive, non-metastatic breast cancer
Prognostic and predictive factors in early, non-metastatic breast cancer
Prognostic and predictive factors in metastatic breast cancer
Sentinel lymph node biopsy in breast cancer: Techniques
Adjuvant endocrine and targeted therapy for postmenopausal women with hormone receptor-positive breast cancer
Hormone receptors in breast cancer: Clinical utility and guideline recommendations to improve test accuracy
Managing the side effects of tamoxifen and aromatase inhibitors
Mechanisms of action of selective estrogen receptor modulators and down-regulators
Menopausal hormone therapy and the risk of breast cancer
Selective estrogen receptor modulators and aromatase inhibitors for breast cancer prevention
Treatment approach to metastatic hormone receptor-positive, HER2-negative breast cancer: Endocrine therapy and targeted agents
Breast cancer-associated lymphedema
Clinical features and diagnosis of peripheral lymphedema
Clinical staging and conservative management of peripheral lymphedema
Breast cancer in men
Hormone receptors in breast cancer: Clinical utility and guideline recommendations to improve test accuracy
Inflammatory breast cancer: Pathology and molecular pathogenesis
Pathology of breast cancer
Prognostic and predictive factors in early, non-metastatic breast cancer
Prognostic and predictive factors in metastatic breast cancer
Sentinel lymph node biopsy in breast cancer: Techniques
Acute side effects of adjuvant chemotherapy for early-stage breast cancer
Adjuvant endocrine and targeted therapy for postmenopausal women with hormone receptor-positive breast cancer
Adjuvant endocrine therapy for premenopausal women with hormone receptor-positive breast cancer
Adjuvant radiation therapy for women with newly diagnosed, non-metastatic breast cancer
Adjuvant systemic therapy for HER2-positive breast cancer
Axillary node metastases with occult primary breast cancer
Brain metastases in breast cancer
Breast cancer in men
Breast sarcoma: Epidemiology, risk factors, clinical presentation, diagnosis, and staging
Breast sarcoma: Treatment
Cardiotoxicity of radiation therapy for breast cancer and other malignancies
Cardiotoxicity of trastuzumab and other HER2-targeted agents
Choice of neoadjuvant chemotherapy for HER2-negative breast cancer
Contralateral prophylactic mastectomy
Deciding when to use adjuvant chemotherapy for hormone receptor-positive, HER2-negative breast cancer
ER/PR negative, HER2-negative (triple-negative) breast cancer
General principles of neoadjuvant management of breast cancer
HER2 and predicting response to therapy in breast cancer
Implant-based breast reconstruction and augmentation
Inflammatory breast cancer: Clinical features and treatment
Neoadjuvant management of newly diagnosed hormone-positive breast cancer
Neoadjuvant therapy for patients with HER2-positive breast cancer
Overview of breast reconstruction
Overview of management of the regional lymph nodes in breast cancer
Overview of the approach to early breast cancer in older women
Overview of the approach to metastatic breast cancer
Overview of the treatment of newly diagnosed, invasive, non-metastatic breast cancer
Paget disease of the breast (PDB)
Phyllodes tumors of the breast
Radiation therapy techniques for newly diagnosed, non-metastatic breast cancer
Selection and administration of adjuvant chemotherapy for HER2-negative breast cancer
Sentinel lymph node biopsy in breast cancer: Techniques
Surgery and radiation for locoregional recurrences of breast cancer
Systemic therapy for locoregionally recurrent breast cancer
Systemic treatment for HER2-positive metastatic breast cancer
The role of local therapies in metastatic breast cancer
The roles of diet, physical activity, and body weight in cancer survivors
Treatment approach to metastatic hormone receptor-positive, HER2-negative breast cancer: Endocrine therapy and targeted agents
Treatment of endocrine therapy resistant/refractory hormone receptor-positive, HER2-negative advanced breast cancer
Treatment of metastatic breast cancer in older women
Use of osteoclast inhibitors in early breast cancer